Literature DB >> 35702580

Differential diagnosis in Rosai-Dorfman disease: A rare case of isolated hepatic presentation mimicking a metastatic tumor with positive 18-FDG uptake.

Carlo Gazia1, Luca Giordano1,2, Maria Grazia Diodoro3, Iacopo Compalati1,4, Riccardo Avantifiori1,2, Gian Luca Grazi1.   

Abstract

Rosai-Dorfman disease (RDD) is also called sinus histiocytosis with massive lymphadenopathy, and it is caused by a histiocytic disorder with unclear etiology. It usually involves cervical lymph nodes, but it may also present with extranodal involvement. We report a rare condition of isolated hepatic RDD without nodal involvement, clinically manifested with three-month abdominal pain and tenderness of the right hypochondrium. CT- and PET-CT scans were compatible with a secondary lesion from an unknown primary tumor. Therefore, the patient underwent an atypical liver resection. Immunohistochemistry and histological results were compatible with a diagnosis of RDD. RDD is characterized by phenomena of emperipolesis, histiocytic proliferation and positive immunostaining for CD14, CD68 and S-100 protein. Cases of isolated gastrointestinal localization of RDD are particularly rare, especially in the liver. Instrumental exams might confuse RDD with other malignancies. RDD is a rare entity, which might be misdiagnosed using PET-CT due to its similarities with malignant tumors. An accurate multidisciplinary approach may help to clear diagnostic clues of this uncommon disease. 2022, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  Rosai-Dorfman disease; hepatectomy; liver surgery; sinus histiocytosis

Year:  2022        PMID: 35702580      PMCID: PMC9161131          DOI: 10.5582/irdr.2022.01037

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  9 in total

1.  Rosai-Dorfman disease: a case with lymphadenopathy and liver involvement.

Authors:  Anu Maheshwari; Anju Seth; Monisha Choudhury; Varun Aggarwal; Bijoy Patra; Shilpi Aggarwal; Sharmila B Mukherjee; Satinder Aneja
Journal:  J Pediatr Hematol Oncol       Date:  2009-03       Impact factor: 1.289

2.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine.

Authors:  M Tasso; C Esquembre; E Blanco; C Moscardó; M Niveiro; A Payá
Journal:  Pediatr Blood Cancer       Date:  2006-10-15       Impact factor: 3.167

Review 3.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity.

Authors:  E Foucar; J Rosai; R Dorfman
Journal:  Semin Diagn Pathol       Date:  1990-02       Impact factor: 3.464

4.  Extranodal Rosai Dorfman disease mimicking multiple liver metastases.

Authors:  Che Liu; Peng Liu
Journal:  Hepatobiliary Surg Nutr       Date:  2021-04       Impact factor: 7.293

Review 5.  Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment.

Authors:  Samir Dalia; Elizabeth Sagatys; Lubomir Sokol; Timothy Kubal
Journal:  Cancer Control       Date:  2014-10       Impact factor: 3.302

6.  Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

Authors:  J Rosai; R F Dorfman
Journal:  Arch Pathol       Date:  1969-01

Review 7.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

8.  18F-FDG PET/CT Imaging of Extranodal Rosai-Dorfman Disease with Hepatopancreatic Involvement - A Pictorial and Literature Review.

Authors:  Faiq Shaikh; Omer Awan; Sohaib Mohiuddin; Saleem Farooqui; Salman A Khan; William McCartney
Journal:  Cureus       Date:  2015-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.